Jammu (NVI): The CSIR-Indian Institute of Integrative Medicine (IIIM), signed an agreement on cannabis scientific research with IndusCann, a Canadian company, here today in the presence of the Union minister and R R Bhatnagar, the advisor to Jammu and Kashmir Lt Governor G C Murmu.
On Addressing the gathering, Dr Jitendra Singh said that this is the landmark day for the entire J&K which will be remembered by future generations as a day of immense significance.
The Minister said that this agreement will give an opportunity to reintroduce cannabis for the welfare of mankind adding that the medicines developed from cannabis.
“The patent on the medicines developed from cannabis will be a major source of revenue for J&K and India as a whole,” the Minister asserted adding that this also has a huge potential for generating investments besides creating employment opportunities and doubling the income of farmers.
Jitendra Singh also said that through this agreement, huge contribution has been made by CSIR and IIIM in realising what can be achieved in J&K after the abrogation of Article 370.
Speaking on the occasion, Advisor to Lieutenant Governor, Rajeev Rai Bhatnagar said that the cannabis has a very high medicinal value besides varied benefits in treating cancer, epilepsy and other dreaded diseases.
Earlier, Director IIIM, Ram Vishwakarma said that IIIM Jammu is globally recognised for its cannabis work. He gave a detailed presentation on the benefits of drugs developed from cannabis like Sativex and Epidolex in treating cancer, epilepsy and other ailments.
